Last edition
News about "ankylosing spondylitis "
China's NMPA Accepts Akeso's Gumukimab sNDa for Ankylosing Spondylitis
China’s NMPA gives approval to Akeso’s gumokimab for the treatment of active ankylosing spondylitis, supported by Phase III data showing significant symptom relief and functional improvement.
Ankylosing Spondylitis | 20/01/2026 | By News Bureau | 232
Biocon Pharma Receives US FDA Nod for Tofacitinib Extended-Release Tablets
Biocon Pharma has received approval from the US Food and Drug Administration (US FDA) for its ANDA for tofacitinib extended-release tablets, securing final approval for the 11 mg strength and tentative approval for the 22 mg strength.
Ankylosing Spondylitis | 19/11/2025 | By Dineshwori | 272
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy